Breast Cancer

It's a little bit difficult to tease out because now you have her too low breast cancer approval. And sometimes a lot of biomarker analysis needs to be done, but that this is this is an important new concept and it could deliver a breakthrough drug for many many patients in need. The destiny long before is still a little bit of time away,. This is an international trial that we're doing across North America...